CD274 and hepatocellular carcinoma: The combination of the ATO/PFH NPs@Au‐cRGD nano drug delivery system and anti-programmed cell death 1 (PD-L1) antibody can achieve synergistic treatment of HCC, which can effectively inhibit liver orthotopic tumors and lung metastases and can intuitively evaluate the treatment effect through visual imaging (87).